Addario Lung Cancer Medical Institute (ALCMI)
banner
alcmi.bsky.social
Addario Lung Cancer Medical Institute (ALCMI)
@alcmi.bsky.social
The Addario Lung Cancer Medical Institute (ALCMI) is a non-profit international consortium comprised of over 25 of the world's premier oncology research institutions. We fund and support investigator-led lung cancer clinical trials.
Please consider referring your small cell lung cancer patients to the SUCCEED Study. Now enrolling! #lungcancer #sclc #clinicaltrials alcmi.org/succeed
October 13, 2025 at 1:02 PM
On this day of reflection, we honor every person who has faced lung cancer, the physicians who help them fight, the advocates working to raise awareness, and the researchers who are leading us toward a brighter future.
#worldlungcancerday #lungcancer
August 1, 2025 at 2:01 PM
The SUCCEED Study, led by Dr. Christine Lovly, is now enrolling patients. Learn more at alcmi.org/clinical-tri...
#lungcancer #sclc
July 30, 2025 at 4:01 PM
Calling all lung cancer physicians and researchers! If you’re caring for patients with small cell lung cancer, we invite you to refer eligible individuals to the SUCCEED Study, a prospective observational study now enrolling people across the U.S. #lungcancer #sclc
July 14, 2025 at 2:04 PM
Happy 4th of July from all of us at ALCMI! As we celebrate independence and community, we're grateful for the dedication and hard work that drives progress in our field. Wishing everyone a safe and joyful holiday. #lungcancer
July 4, 2025 at 2:03 PM
At ALCMI, we're dedicated to advancing lung cancer research and improving patient outcomes. Today, we're thrilled to announce that we're preparing to make a significant commitment to small cell lung cancer (SCLC) research. #lungcancer #sclc
March 17, 2025 at 3:00 PM
We're currently enrolling people in our ENIGMA study, and we can use your help. Our study, developed with Massachusetts General Hospital and GO2 for Lung Cancer, aims to understand why tumor resistance develops with ALK+ targeted therapy. Learn more here buff.ly/43cx3rM
March 4, 2025 at 4:01 PM
We're here exhibiting at Targeted Therapies for Lung Cancer in Huntington Beach, CA, and ready to talk about your next research project! Stop by to see how we can help with funding, staffing, and support! #lungcancer #ttlc25
February 20, 2025 at 5:01 PM
Starting today, this week, we're at the 2025 Targeted Therapies of Lung Cancer Meeting! We're exhibiting at Table #8. If you're here in Huntington Beach, stop by to say hi! We'd love to introduce ourselves and tell you how we accelerate investigator-initiated clinical trials. #lungcancer #TTLC25
February 19, 2025 at 5:10 PM
Are you going to the IASLC 2025 Targeted Therapies of Lung Cancer in Huntington Beach, CA? We'll be there and would love to connect. Stop by to say hi! #lungcancer
February 14, 2025 at 2:00 PM
Pioneering research led by Dr. Antonious Hazim, Dr. Konstantinos Leventakos, and Dr. Vinicius Ernani, and published in JCO Oncology Practice, explores the transformative potential of immunomodulatory agents in tackling small cell lung cancer. #lungcancer
https://buff.ly/4gshFuw
February 11, 2025 at 3:00 PM
Are you a lung cancer researcher? Do have an idea for a clinical trial? If so, we should talk. We accelerate investigator-initiated clinical trials by providing funding, support, specimen collection, and more. Visit us at alcmi.org. #lungcancer
February 6, 2025 at 4:00 PM
Big strides are being made in the battle against small cell lung cancer (SCLC). A recent review published in the journal Cancers highlights a promising new wave of therapies targeting specific molecular pathways. #lungcancer
https://buff.ly/3WGTZvq
February 4, 2025 at 4:00 PM
On this World Cancer Day, we honor the patients, families, physicians, and researchers who have confronted this disease. We look forward to a healthier, happier, cancer-free future. #worldcancerday #lungcancer
February 4, 2025 at 3:00 PM